未登录

X

Xin Gui

tong ji university

H指数:17

被引数:1,226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Smart nanozymes coupled with dynamic magnet field and laser exposures for cancer therapy

JOURNAL OF COLLOID AND INTERFACE SCIENCE

IF9.7

2024-12-010

PRE

miR-153 promotes neural differentiation by activating the cell adhesion/Ca2+signaling pathway and targeting ion channel activity in HT-22 cells by bioinformatic analysis

IF3.6

2024-05-010

OAAI

Oxygen and hydrogen peroxide self-supplying magnetic nanoenzymes for cancer therapy through magneto -mechanical force, force -induced reactive oxygen species, chemodynamic effects, and cytotoxicity of Ca2+ ions

IF9

2023-01-218

PRE

Magnetotactic Bacteria-Based Drug-Loaded Micromotors for Highly Efficient Magnetic and Biological Double-Targeted Tumor Therapy

基于趋磁细菌的载药微电机用于高效磁和生物双靶向肿瘤治疗

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-01-0623

PRE

CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells

MOLECULAR THERAPY NUCLEIC ACIDS

IF6.1

2021-03-0138

OAAI

Identification of miRNA-Target Gene Pairs in the Parietal and Frontal Lobes of the Brain in Patients with Alzheimer's Disease Using Bioinformatic Analyses

NEUROCHEMICAL RESEARCH

IF3.8

2021-02-1311

PREAI

Fluorescent hollow mesoporous carbon spheres for drug loading and tumor treatment through 980-nm laser and microwave co-irradiation

980纳米激光和微波共辐照荧光中空介孔碳球载药及肿瘤治疗

IF12.9

2020-07-0134

PREAI

miR-155 Accelerates the Growth of Human Liver Cancer Cells by Activating CDK2 via Targeting H3F3A

MOLECULAR THERAPY-ONCOLYTICS

IF0

2020-06-0117

OAAI

miR24-2 Promotes Malignant Progression of Human Liver Cancer Stem Cells by Enhancing Tyrosine Kinase Src Epigenetically

MOLECULAR THERAPY

IF12

2020-02-0124

OAAI

Long noncoding RNA HULC accelerates the growth of human liver cancer stem cells by upregulating CyclinD1 through miR675-PKM2 pathway via autophagy

STEM CELL RESEARCH & THERAPY

IF7.3

2020-01-0318

OAAI

miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2019-03-017

OAAI

Graphitic carbon nanocages as new photothermal agent and drug Carrier for 980-nm-laser-driven cancer therapy

IF11.6

2018-09-0124

PREAI

Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a

MOLECULAR CANCER

IF33.9

2018-06-12174

OAAI

miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2018-06-0122

OAAI

RETRACTED: Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling (Retracted article. See vol. 31, pg. 13, 2023)

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2018-06-018

OAAI

Isolation of Exosome-Like Nanoparticles and Analysis of MicroRNAs Derived from Coconut Water Based on Small RNA High-Throughput Sequencing

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

IF6.2

2018-02-2596

PREAI

Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN

CELL DEATH & DISEASE

IF9.6

2018-02-15103

OAAI

Inflammatory cytokine IL6 cooperates with CUDR to aggravate hepatocyte-like stem cells malignant transformation through NF-κB signaling

SCIENTIFIC REPORTS

IF3.9

2016-11-1122

OAAI

RETRACTED: SET1A Cooperates With CUDR to Promote Liver Cancer Growth and Hepatocyte-like Stem Cell Malignant Transformation Epigenetically (Retracted article. See vol. 31, pg. 1496, 2023)

MOLECULAR THERAPY

IF12

2016-02-0143

OA

Long Noncoding RNA CUDR Regulates HULC and β-Catenin to Govern Human Liver Stem Cell Malignant Differentiation

MOLECULAR THERAPY

IF12

2015-12-0171

OAAI